These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6616979

  • 1. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
    Masur H, Francioli P, Ruddy M, Murray HW.
    Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
    [Abstract] [Full Text] [Related]

  • 2. Staphylococcal sepsis in patients on chronic hemodialysis regimens: intravenous treatment with vancomycin given once weekly.
    Barcenas CG, Fuller TJ, Elms J, Cohen R, White MG.
    Arch Intern Med; 1976 Oct; 136(10):1131-4. PubMed ID: 971012
    [Abstract] [Full Text] [Related]

  • 3. Are serum levels of vancomycin useful in the first week of therapy?
    Goldstein E, Bartholomew WR, Vickers MK, Parr T.
    Mo Med; 1995 Sep; 92(9):596-9. PubMed ID: 7476836
    [Abstract] [Full Text] [Related]

  • 4. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
    Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A.
    Arch Intern Med; 2006 Oct 23; 166(19):2138-44. PubMed ID: 17060545
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology and efficacy of vancomycin for staphylococcal infections in children.
    Schaad UB, Nelson JD, McCracken GH.
    Rev Infect Dis; 1981 Oct 23; 3 suppl():S282-8. PubMed ID: 7342292
    [Abstract] [Full Text] [Related]

  • 6. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.
    Zimmermann AE, Katona BG, Plaisance KI.
    Pharmacotherapy; 1995 Oct 23; 15(1):85-91. PubMed ID: 7739950
    [Abstract] [Full Text] [Related]

  • 7. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.
    Clin Ther; 2007 Jun 23; 29(6):1107-15. PubMed ID: 17692725
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF, Dreitlein WB, Steward CA, Kapoian T, Walker JA, Sherman RA.
    Clin Nephrol; 1998 Jul 23; 50(1):51-5. PubMed ID: 9710347
    [Abstract] [Full Text] [Related]

  • 9. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
    Glover ML, Cole E, Wolfsdorf J.
    J Crit Care; 2000 Mar 23; 15(1):1-4. PubMed ID: 10757191
    [Abstract] [Full Text] [Related]

  • 10. [Optimal vancomycin serum level in Staphylococcus aureus infections?].
    Bingen E, Mariani-Kurkdjian P, Nebbad B.
    Med Mal Infect; 2006 Sep 23; 36(9):439-42. PubMed ID: 17027219
    [Abstract] [Full Text] [Related]

  • 11. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.
    Chang FY, Peacock JE, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.
    Medicine (Baltimore); 2003 Sep 23; 82(5):333-9. PubMed ID: 14530782
    [Abstract] [Full Text] [Related]

  • 12. The role of vancomycin in the treatment paradigm.
    Stevens DL.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S51-7. PubMed ID: 16323121
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin population pharmacokinetics in neonates.
    de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN.
    Clin Pharmacol Ther; 2000 Apr 01; 67(4):360-7. PubMed ID: 10801244
    [Abstract] [Full Text] [Related]

  • 14. Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule.
    Plan O, Cambonie G, Barbotte E, Meyer P, Devine C, Milesi C, Pidoux O, Badr M, Picaud JC.
    Arch Dis Child Fetal Neonatal Ed; 2008 Nov 01; 93(6):F418-21. PubMed ID: 18450803
    [Abstract] [Full Text] [Related]

  • 15. Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer.
    Safdar A, Rolston KV.
    Cancer; 2006 Apr 15; 106(8):1815-20. PubMed ID: 16534785
    [Abstract] [Full Text] [Related]

  • 16. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.
    Clin Infect Dis; 2008 Jan 15; 46(2):193-200. PubMed ID: 18171250
    [Abstract] [Full Text] [Related]

  • 17. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA, Ariano RE, McCrae ML, Vercaigne LM.
    Clin Infect Dis; 2012 Aug 15; 55(4):527-33. PubMed ID: 22573855
    [Abstract] [Full Text] [Related]

  • 18. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
    Schaedeli F, Uehlinger DE.
    Clin Pharmacol Ther; 1998 Jan 15; 63(1):26-38. PubMed ID: 9465839
    [Abstract] [Full Text] [Related]

  • 19. [Study of serum kinetics of vancomycin during the "antibiotic-lock" technique].
    Elian JC, Frappaz D, Ros A, Gay JP, Guichard D, Dorche G, Aubert G, Bouteille M, Ollagnier M, Freycon F.
    Arch Fr Pediatr; 1992 Apr 15; 49(4):357-60. PubMed ID: 1497425
    [Abstract] [Full Text] [Related]

  • 20. [Prospective study of 75 episodes of sepsis in hemodialysed patients].
    Martínez JA, Gatell JM, Montoliu J, Lens XM, Cases A, López-Pedret J, Revert L.
    Med Clin (Barc); 1989 Jan 21; 92(2):47-51. PubMed ID: 2709887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.